Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

366

Participants

Timeline

Start Date

October 29, 2009

Primary Completion Date

July 1, 2010

Study Completion Date

July 1, 2010

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Fluticasone propionate/salmeterol combination product

Fluticasone propionate/salmeterol combination product 250/50mcg DISKUS twice a day for 8 weeks

DRUG

Salmeterol

Salmeterol 50mcg DISKUS twice a day for 8 weeks

DRUG

Placebo

Placebo DISKUS twice a day for 8 weeks

Trial Locations (39)

16508

GSK Investigational Site, Erie

19140

GSK Investigational Site, Philadelphia

23229

GSK Investigational Site, Richmond

24210

GSK Investigational Site, Abingdon

27909

GSK Investigational Site, Elizabeth City

28207

GSK Investigational Site, Charlotte

29303

GSK Investigational Site, Spartanburg

29325

GSK Investigational Site, Clinton

29340

GSK Investigational Site, Gaffney

29640

GSK Investigational Site, Easley

29646

GSK Investigational Site, Greenwood

29678

GSK Investigational Site, Seneca

29706

GSK Investigational Site, Chester

30033

GSK Investigational Site, Decatur

30046

GSK Investigational Site, Lawrenceville

33321

GSK Investigational Site, Tamarac

35501

GSK Investigational Site, Jasper

36608

GSK Investigational Site, Mobile

37601

GSK Investigational Site, Johnson City

42431

GSK Investigational Site, Madisonville

44718

GSK Investigational Site, Canton

45231

GSK Investigational Site, Cincinnati

46617

GSK Investigational Site, South Bend

47710

GSK Investigational Site, Evansville

47714

GSK Investigational Site, Evansville

63141

GSK Investigational Site, St Louis

70115

GSK Investigational Site, New Orleans

70584

GSK Investigational Site, Sunset

77054

GSK Investigational Site, Houston

78130

GSK Investigational Site, New Braunfels

80033

GSK Investigational Site, Wheat Ridge

92506

GSK Investigational Site, Riverside

97035

GSK Investigational Site, Lake Oswego

97213

GSK Investigational Site, Portland

99204

GSK Investigational Site, Spokane

90095-1690

GSK Investigational Site, Los Angeles

06902

GSK Investigational Site, Stamford

07091

GSK Investigational Site, Summit

29406-7108

GSK Investigational Site, Charleston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY